Selskabsmeddelelse nr. 26, 2015 - Ugentlig oplysning om førtidige indfrielser i Nordea Kredit (CK 93) pr. 20. februar 2015.
February 23, 2015 03:50 ET
|
Nordea Kredit Realkreditaktieselskab
Nordea Kredit offentliggør hermed den ugentlige oversigt over førtidige
indfrielser af konverterbare lån til fremtidige terminer.
Oplysningerne er omfattet af offentliggørelseskravet i...
Lánasjóður sveitarfélaga - Útboð LSS150224 & LSS150434
February 23, 2015 03:45 ET
|
Lánasjóður sveitarfélaga ohf
Lánasjóður sveitarfélaga hefur ákveðið að efna til útboðs á skuldabréfum í flokki LSS150224 og LSS150434 þriðjudaginn 24. febrúar 2015. Lánasjóðurinn stefnir að því að taka tilboðum að fjárhæð 500...
Data on OMX Baltic Benchmark Fund issued shares as of February 20, 2015
February 23, 2015 03:42 ET
|
Orion Asset Management
Vilnius, Lithuania, 2015-02-23 09:42 CET (GLOBE NEWSWIRE) --
OMX Baltic Benchmark Fund share price on February 20, 2015 – 7.6857 EUR
OMX Baltic Benchmark Fund number of shares issued...
SUOMINEN OYJ: SHARES SUBSCRIBED WITH HYBRID BOND
February 23, 2015 03:37 ET
|
Nasdaq Helsinki Oy
EXCHANGE NOTICE, 23 FEBRUARY 2015 SHARES
SUOMINEN OYJ: SHARES SUBSCRIBED WITH HYBRID BOND
A total of 1 462 069 shares have been subscribed with the
hybrid bond of Suominen...
IT – Genium INET Test – Disturbance External Test System 3
February 23, 2015 03:35 ET
|
Fixed Income
We are currently experiencing a disturbance on External Test System 3.
Impact
External Test System 3 is currently unavailable for all testing
Update
We are currently working on solving...
IT – Genium INET Test – Disturbance External Test System 3
February 23, 2015 03:31 ET
|
Derivatives
We are currently experiencing a disturbance on External Test System 3.
Impact
External Test System 3 is currently unavailable for all testing
Update
We are currently working on solving...
BioGaias dotterbolag Infant Bacterial Therapeutics får klassificering som särläkemedel i Europa
February 23, 2015 03:30 ET
|
BioGaia AB
Infant Bacterial Therapeutics (IBT), dotterbolag till BioGaia, är i ett tidigt
skede av att utveckla ett läkemedel för att förebygga nekrotiserande enterokolit
(NEC), vilket är en sällsynt och dödlig...
BioGaia subsidiary Infant Bacterial Therapeutics gets Orphan Drug Designation in Europe
February 23, 2015 03:30 ET
|
BioGaia AB
Infant Bacterial Therapeutics (IBT), subsidiary of BioGaia, is in the early
stages of developing a drug to prevent necrotizing enterocolitis (NEC) which is
a rare and fatal disease that affects...
Primco Management ESMG Ready to Launch Downtown Attraction
February 23, 2015 03:30 ET
|
Primco Management, Inc.
SEATTLE, Feb. 23, 2015 (GLOBE NEWSWIRE) -- Primco Management Inc. (OTCBB:PMCM), a medical marijuana, real estate management and multi-media company announces the long awaited release of Downtown...
IT – Genium INET Test – Disturbance External Test System 3
February 23, 2015 03:27 ET
|
Nasdaq Commodities
We are currently experiencing a disturbance on External Test System 3.
Impact
External Test System 3 is currently unavailable for all testing
Update
We are currently working on...
- June 15, 2024 08:57 ET MULTIMEDIA UPDATE -- Rygen Technologies Launches Next-Gen Supply Chain Solution: AI-enabled TMS
- June 14, 2024 21:21 ET Pik'r Range Picking Robot Enhances U.S. Open Experience at Pinehurst